Platelet-activating factor antagonist (ABT-491) decreases neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury

Brain Research

Volumn 1143, Issue 1, 2007, Pages 193-198

  Bozlu, Gulcin ^a   Atici, Aytug ^b   Turhan, Ali Haydar ^b   Polat, Ayse ^b   Nayci, Ali ^b   Okuyaz, Cetin ^b   Taskinlar, Hakan ^b  

^a Tarsus Devlet Hastanesi ^*  (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

ABT 491; Apoptosis; Brain injury; Hypoxia; Ischemia; PAF

Indexed keywords

4 ETHYNYL 3 [3 FLUORO 4 [(2 METHYL 1H IMIDAZO[4,5 C]PYRIDIN 1 YL)METHYL]BENZOYL] N,N DIMETHYL 1H INDOLE 1 CARBOXAMIDE; CASPASE 3; NITROGEN; OXYGEN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY LIGATION; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; FEMALE; MALE; NERVE CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CASPASE 3; CELL COUNT; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HYPOXIA-ISCHEMIA, BRAIN; IMIDAZOLES; IN SITU NICK-END LABELING; INDOLES; PLATELET ACTIVATING FACTOR; RATS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 33947323018     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.094     Document Type: Article

References (31)

1. Albert D.H., Magoc T.J., Tapang P., Luo G., Morgan D.W., Curtin M., Sheppard G.S., Xu L., Heyman H.R., Davidsen S.K., Summers J.B., and Carter G.W. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist. Eur. J. Pharmacol. 325 (1997) 69-80
2. Aldemir M., Bosnak M., Al B., Buyukbayram H., and Tacyildiz I. Effects of molsidomine and lexipafant in hepatic ischemia-reperfusion injury. Injury 35 (2004) 232-237
3. Bazan N.G. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J. Lipid Res. 44 (2003) 2221-2233
4. Blomgren K., and Hagberg H. Free radicals, mitochondria, and hypoxia-ischemia in developing brain. Free Radical Biol. Med. 40 (2006) 388-397
5. Chen C., and Bazan N.G. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Prostaglandins Other Lipid Mediators 77 (2005) 65-76
6. Ferriero D.M. Neonatal brain injury. N. Engl. J. Med. 351 (2004) 1985-1995
7. Ferriero D.M. Protecting neurons. Epilepsia 46 Suppl. 7 (2005) 45-51
8. Grypioti A.D., Theocharis S.E., Demopoulos C.A., Papadopoulou-Daifoti Z., Basayiannis A.C., and Mykoniatis M.G. Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats. Liver Int. 26 (2006) 97-105
9. Hossain M.A. Molecular mediators of hypoxic-ischemic injury and implications for epilepsy in the developing brain. Epilepsy Behav. 7 (2005) 204-213
10. Johnston M.V., Trescher W.H., Ishida A., and Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49 (2001) 735-741
11. Katoh S., Toyama J., Kodama I., Koike A., and Abe T. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309. Cardiovasc. Res. 27 (1993) 1430-1434
12. Liu X.H., Eun B.L., Silverstein F.S., and Barks J.D.E. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr. Res. 40 (1996) 797-803
13. Liu X.H., Eun B.L., and Barks J.D.E. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 49 (2001) 804-811
14. Loucks E.B., Godin D.V., Walley K.R., McManus B.M., Rahimian R., Granville D.J., Hong J.M., Aktary F.M., and Quayumi A.K. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart. Can. J. Cardiol. 19 (2003) 267-274
15. Lu J., Caplan M.S., Saraf A.P., Li D., Adler L., Liu X., and Jilling T. Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells. Am. J. Physiol.: Gastrointest. Liver Physiol. 286 (2004) 340-350
16. Maki N., Hoffman D.R., and Johnston J.M. Platelet activating factor acetylhydrolase activity in maternal, fetal and newborn rabbit plasma during pregnancy and lactation. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 728-732
17. Murohisa G., Kobayashi Y., Kawasaki T., Nakamura S., and Nakamura H. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. Liver 22 (2002) 394-403
18. Northington F.J. Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR J. 47 (2006) 32-38
19. Northington F.J., Graham E.M., and Martin L.J. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?. Brain Res. Brain Res. Rev. 50 (2005) 244-257
20. Oechmichen M., and Meissner C. Cerebral hypoxia and ischemia: the forensic point of view: a review. J. Forensic Sci. 51 (2006) 880-887
21. Perlman J.M. Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics 117 (2006) S28-S33
22. Rice J.E., Vanucci R.C., and Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9 (1981) 131-141
23. Rodrigo J., Fernandez A.P., Serrano J., Peinado M.A., and Martinez A. The role of free radicals in cerebral hypoxia and ischemia. Free Radical Biol. Med. 39 (2005) 26-50
24. Sastry P.S., and Rao K.S. Apoptosis and the nervous system. J. Neurochem. 74 (2000) 1-20
25. Stammberger U., Carboni G.L., Hillinger S., Schneiter D., Weder W., and Schmid R.A. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury. J. Heart Lung Transplant. 18 (1999) 862-868
26. Torras J., Cruzado J.M., Riera M., Condom E., Duque N., Herrero I., Merlos M., Espinosa L., Lloberas N., Egido J., and Grinyo J.M. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. Kidney Int. 56 (1999) 1798-1808
27. Vannucci R.C. Hypoxic-ischemic encephalopathy. Am. J. Perinatol. 17 (2000) 113-120
28. Vannucci R.C., and Vannucci S.J. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev. Neurosci. 27 (2005) 81-86
29. Viswanath M., Palmer C., and Roberts R.L. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection. Pediatr. Res. 48 (2000) 109-113
30. Wu B., Iwakiri R., Ootani A., Fujise T., Tsunada S., and Fujimoto K. Platelet activating factor promotes mucosal apoptosis via FasL mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. FASEB J. 17 (2003) 1156-1158
31. Zhu C., Wang X., Cheng X., Qiu L., Xu F., Simbruner G., and Blomgren K. Post-ischemic hypothermia-induced tissue protection and diminished apoptosis after neonatal cerebral hypoxia-ischemia. Brain Res. 996 (2004) 67-75